Article

wsj.com on 2021-06-07 17:25

First Alzheimer’s Drug to Slow Disease Is Approved by FDA

The Biogen drug was approved after facing controversy over whether it really slows the progression of the memory-robbing disease.

Related news

Alzheimer's drug that could slow disease approved by FDA KVUE News
FDA approves Biogen’s Alzheimer’s drug, the first to slow the disease wsj.com
Alzheimer’s drug that can slow disease gets backing from FDA advisers Alaska Dispatch News
Japan , Indianapolis
FDA Approved Alzheimer’s Drug Despite Some Staff Concerns wsj.com
Cambridge
KUK hosts clinical trial for newly FDA approved Alzheimer’s drug kykernel.com
FDA approved controversial Alzheimer’s drug despite objections from staff New York Post
FDA OKs Alzheimer’s drug that modestly slows disease San Jose Mercury News
Japan
FDA approves Alzheimer’s drug that modestly slows disease pressherald.com
Massachusetts , Cambridge , Japan
Alzheimer’s drug that modestly slows disease OK’d by FDA seattletimes.com
Japan
FDA advisers back drug that can slow Alzheimer’s journalrecord.com
Japan
New details emerge on drug that may slow Alzheimer’s disease Merced Sun-Star
United States , Japan , Cambridge , Mayo Clinic , San Diego
FDA Approves First New Drug To Treat Alzheimer’s Disease In Nearly Twenty Years Forbes
Mayo Clinic